FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2942651424> ?p ?o ?g. }

• W2942651424 endingPage "3154" @default.
• W2942651424 startingPage "3145" @default.
• W2942651424 abstract "Background: Gold nanoparticles (AuNps) are promising agents for prostate cancer therapy. Herein, the in vivo effects of 20 and 50 nm sized AuNps on experimentally induced benign prostatic hyperplasia (BPH) was examined. Materials and methods: Adult male rats were divided into four groups (n=6-8 each). A negative control group and three groups were injected daily with testosterone (3 mg/kg/subcutaneously) to induce BPH. Animals receiving testosterone were randomized to untreated BPH group and two BPH groups which were treated intraperitoneally with 20 and 50 nm AuNps (5 mg/kg/daily) in addition to testosterone. After three weeks, histopathological changes and serum levels of testosterone and dihydrotestosterone (DHT) were analyzed. In addition, the prostate tissue levels of transforming growth factor-β1 (TGF-β1), vascular endothelial growth factor-a (VEGF-A) and interleukin-6 (IL-6) were measured using ELISA. Results: There were significant increases in the prostate weight/body weight ratio, serum testosterone and DHT and in the prostate tissue content of TGF-β1, IL-6 and VEGF-A in the untreated BPH group. histological examination showed morphological abnormalities with more proliferation in the glandular epithelial and stromal area and with abundant epithelial papillary folds in the BPH group. Simultaneous administration of 50 nm AuNps with testosterone tended to increase the prostate weight/body weight ratio and increase the tissue level of IL-6 in compared to the BPH group. Conversely, treatment with 20 nm AuNps significantly reduced the elevated tissue content of TGF-β1, IL-6, and VEGF-A. Histopathological examination also showed that 20 nm but not the 50 nm AuNps administration ameliorates testosterone-induced prostatic hyperplasia. Conclusions: In experimentally induced BPH, AuNps can inhibit the progression of BPH in a size-dependent manner. while 20 nm AuNps ameliorate BPH by its inhibitory effects on the prostatic cell proliferation, inflammation and angiogenesis, the 50 nm AuNps could potentially exacerbate the development of BPH in rats, mainly through enhancing the inflammatory process." @default.
• W2942651424 created "2019-05-09" @default.
• W2942651424 creator A5011301851 @default.
• W2942651424 creator A5025357773 @default.
• W2942651424 creator A5036354449 @default.
• W2942651424 creator A5047869985 @default.
• W2942651424 creator A5082765873 @default.
• W2942651424 date "2019-05-01" @default.
• W2942651424 modified "2023-10-13" @default.
• W2942651424 title "<p>Effect of gold nanoparticles treatment on the testosterone-induced benign prostatic hyperplasia in rats</p>" @default.
• W2942651424 cites W1533510878 @default.
• W2942651424 cites W1731047237 @default.
• W2942651424 cites W1983030304 @default.
• W2942651424 cites W1986001714 @default.
• W2942651424 cites W1986878226 @default.
• W2942651424 cites W1988222534 @default.
• W2942651424 cites W1988976487 @default.
• W2942651424 cites W2000678460 @default.
• W2942651424 cites W2003959927 @default.
• W2942651424 cites W2005233948 @default.
• W2942651424 cites W2016381211 @default.
• W2942651424 cites W2022243569 @default.
• W2942651424 cites W2023049900 @default.
• W2942651424 cites W2026514475 @default.
• W2942651424 cites W2044046581 @default.
• W2942651424 cites W2057185610 @default.
• W2942651424 cites W2058712340 @default.
• W2942651424 cites W2065347960 @default.
• W2942651424 cites W2092630235 @default.
• W2942651424 cites W2094475675 @default.
• W2942651424 cites W2094773318 @default.
• W2942651424 cites W2097103399 @default.
• W2942651424 cites W2106501078 @default.
• W2942651424 cites W2107337149 @default.
• W2942651424 cites W2110669077 @default.
• W2942651424 cites W2154809330 @default.
• W2942651424 cites W2161237410 @default.
• W2942651424 cites W2162760365 @default.
• W2942651424 cites W2274446261 @default.
• W2942651424 cites W2340662778 @default.
• W2942651424 cites W2513249055 @default.
• W2942651424 cites W2525383821 @default.
• W2942651424 cites W2760276005 @default.
• W2942651424 cites W2792033875 @default.
• W2942651424 doi "https://doi.org/10.2147/ijn.s202645" @default.
• W2942651424 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6507074" @default.
• W2942651424 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31118628" @default.
• W2942651424 hasPublicationYear "2019" @default.
• W2942651424 type Work @default.
• W2942651424 sameAs 2942651424 @default.
• W2942651424 citedByCount "27" @default.
• W2942651424 countsByYear W29426514242019 @default.
• W2942651424 countsByYear W29426514242020 @default.
• W2942651424 countsByYear W29426514242021 @default.
• W2942651424 countsByYear W29426514242022 @default.
• W2942651424 countsByYear W29426514242023 @default.
• W2942651424 crossrefType "journal-article" @default.
• W2942651424 hasAuthorship W2942651424A5011301851 @default.
• W2942651424 hasAuthorship W2942651424A5025357773 @default.
• W2942651424 hasAuthorship W2942651424A5036354449 @default.
• W2942651424 hasAuthorship W2942651424A5047869985 @default.
• W2942651424 hasAuthorship W2942651424A5082765873 @default.
• W2942651424 hasBestOaLocation W29426514241 @default.
• W2942651424 hasConcept C121608353 @default.
• W2942651424 hasConcept C126322002 @default.
• W2942651424 hasConcept C126894567 @default.
• W2942651424 hasConcept C134018914 @default.
• W2942651424 hasConcept C167734588 @default.
• W2942651424 hasConcept C16930146 @default.
• W2942651424 hasConcept C2776235491 @default.
• W2942651424 hasConcept C2777025900 @default.
• W2942651424 hasConcept C2777562237 @default.
• W2942651424 hasConcept C2777911890 @default.
• W2942651424 hasConcept C2779279991 @default.
• W2942651424 hasConcept C2779881493 @default.
• W2942651424 hasConcept C2780192828 @default.
• W2942651424 hasConcept C71315377 @default.
• W2942651424 hasConcept C71924100 @default.
• W2942651424 hasConceptScore W2942651424C121608353 @default.
• W2942651424 hasConceptScore W2942651424C126322002 @default.
• W2942651424 hasConceptScore W2942651424C126894567 @default.
• W2942651424 hasConceptScore W2942651424C134018914 @default.
• W2942651424 hasConceptScore W2942651424C167734588 @default.
• W2942651424 hasConceptScore W2942651424C16930146 @default.
• W2942651424 hasConceptScore W2942651424C2776235491 @default.
• W2942651424 hasConceptScore W2942651424C2777025900 @default.
• W2942651424 hasConceptScore W2942651424C2777562237 @default.
• W2942651424 hasConceptScore W2942651424C2777911890 @default.
• W2942651424 hasConceptScore W2942651424C2779279991 @default.
• W2942651424 hasConceptScore W2942651424C2779881493 @default.
• W2942651424 hasConceptScore W2942651424C2780192828 @default.
• W2942651424 hasConceptScore W2942651424C71315377 @default.
• W2942651424 hasConceptScore W2942651424C71924100 @default.
• W2942651424 hasLocation W29426514241 @default.
• W2942651424 hasLocation W29426514242 @default.
• W2942651424 hasLocation W29426514243 @default.
• W2942651424 hasLocation W29426514244 @default.
• W2942651424 hasOpenAccess W2942651424 @default.

• next